Which aspect is NOT typically considered in therapeutic outcomes assessment?

Therapeutic outcomes assessment focuses on evaluating whether a particular treatment is effective in achieving the desired health results for patients. This encompasses several factors that directly relate to patient health and the overall effectiveness of the medications prescribed.

Evaluating the brand reputation of the pharmacy does not typically fall under therapeutic outcomes assessment because it does not directly influence the clinical outcomes of a patient's treatment regimen. Unlike patient adherence, which measures how well patients follow their medication plans and impacts their health outcomes, or the cost of medications, which affects accessibility and adherence, the brand reputation has no direct effect on the effectiveness of the therapy provided. Similarly, assessing side effects is integral to understanding the safety and tolerability of a medication, which directly relates to the therapeutic outcome for the patient.

The other aspects—patient adherence, medication costs, and side effects—are all critical factors that can significantly affect whether a patient achieves the intended health benefits from their treatment. They are part of a comprehensive evaluation process in therapeutic outcomes assessment, making the brand reputation of the pharmacy the least relevant factor in this context.